Vicore Pharma Holding Stock Profit Margin
| VICO Stock | SEK 7.72 0.07 0.92% |
Vicore Pharma Holding fundamentals help investors to digest information that contributes to Vicore Pharma's financial success or failures. It also enables traders to predict the movement of Vicore Stock. The fundamental analysis module provides a way to measure Vicore Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vicore Pharma stock.
Vicore |
Vicore Pharma Holding Company Profit Margin Analysis
Vicore Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Vicore Pharma Holding has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all Sweden stocks is 100.0% lower than that of the firm.
Vicore Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vicore Pharma's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vicore Pharma could also be used in its relative valuation, which is a method of valuing Vicore Pharma by comparing valuation metrics of similar companies.Vicore Pharma is currently under evaluation in profit margin category among its peers.
Vicore Fundamentals
| Return On Equity | -0.99 | |||
| Return On Asset | -0.49 | |||
| Current Valuation | 1.22 B | |||
| Shares Outstanding | 81.85 M | |||
| Shares Owned By Insiders | 16.14 % | |||
| Shares Owned By Institutions | 51.89 % | |||
| Price To Earning | 163.82 X | |||
| Price To Book | 8.67 X | |||
| EBITDA | (293.13 M) | |||
| Net Income | (296.48 M) | |||
| Cash And Equivalents | 215.97 M | |||
| Cash Per Share | 5.10 X | |||
| Total Debt | 320 K | |||
| Current Ratio | 19.83 X | |||
| Book Value Per Share | 2.24 X | |||
| Cash Flow From Operations | (265.17 M) | |||
| Earnings Per Share | (4.76) X | |||
| Target Price | 69.6 | |||
| Number Of Employees | 23 | |||
| Beta | 0.59 | |||
| Market Capitalization | 1.26 B | |||
| Total Asset | 451.17 M | |||
| Net Asset | 451.17 M |
About Vicore Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vicore Pharma Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vicore Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vicore Pharma Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.